White Papers


TissueGen White Paper Download

Controlled Sustained Delivery of Biologics and Pharmaceuticals from ELUTE® Fiber Enabling the Future of Medicine

Controlled Sustained Delivery of Biologics and Pharmaceuticals from ELUTE Fiber Enabling the Future of Medicine
Incorporating biologics or pharmaceuticals into biodegradable fibers that can serve as either monofilament or textile structures for medical devices or tissue scaffolds has the potential to add significant value to the field of medicine. Typically, medical fibers are manufactured through melt-extrusion at high temperatures and high shear stress, thereby severely limiting the types of biologics and pharmaceuticals that can remain viable through the manufacturing process. To address these limitations, TissueGen, Inc. developed and patented a modified wet-extrusion process to manufacture its commercially available product, ELUTE® fiber, at or below body temperature and with relatively low shear stress.

 

White Paper Download

Your Name: (required)

Company:

Your Email: (required)

Phone:

captcha